25.06.2019 | Letter to the Editor
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials
Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2019
Einloggen, um Zugang zu erhalten